Results 201 to 210 of about 310,703 (307)

High expression of miR5700 in atypical type A thymoma and its role in promoting tumour progression

Clinical and Translational Discovery, Volume 6, Issue 1, February 2026.
The first discovery of miR5700 in tumour progression: 1. Atypical type A thymoma was the most invasive and metastatic subtype of thymic epithelial tumour, and difficult to diagnose in pathology owing to the scarcity of specific biomarkers and well‐defined molecular targets. 2. miR‐5700 was markedly overexpressed in atypical type A thymoma. 3.
Li Zhao, Yi‐Yang Chen, Li‐Yang Li, Yun‐Lan Tao, Gang Chen   +4 more
wiley   +1 more source

Correction: Mechanisms of metabolic transition in hypertrophic cardiomyopathy. [PDF]

Front Physiol
Tan C, Guo Z, Zhou J, Yuan W.
europepmc   +1 more source

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.

Journal of the American College of Cardiology, 2020
Carolyn Y. Ho, M. Mealiffe, R. Bach, Mondira Bhattacharya, L. Choudhury, J. Edelberg, Sheila M. Hegde, D. Jacoby, N. Lakdawala, S. Lester, Yanfei Ma, A. Marian, S. Nagueh, A. Owens, F. Rader, S. Saberi, A. Sehnert, M. Sherrid, S. Solomon, Andrew Wang, O. Wever-Pinzon, T. Wong, S. Heitner   +22 more
semanticscholar   +1 more source

Heyde Syndrome: A Literature Review

Health Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims Heyde syndrome, a triad of anemia from gastrointestinal (GI) bleeding, aortic valve stenosis, and acquired von Willebrand syndrome, primarily affects individuals over 65. Management requires a multidisciplinary approach, including medical therapy, endoscopic intervention, and valve replacement.
Yashika Gupta, Abdul Rehman Shahid Khan, Viraj Shetty, Yeshwini Murali Krishna, Ayisha Maqsood, Muhammad Husnain Ahmad, Masab Ali, Betsy Samuel, Ali Gohar, Abdul Waheed, Muhammad Bilal Afzal, Rehan Naseer Ahmad, Saqib Maqsood   +12 more
wiley   +1 more source

Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Circulation Research, 2017
A. Marian, E. Braunwald
semanticscholar   +1 more source

Current Trends in Duchenne Muscular Dystrophy Research and Therapy: 3D Cardiac Modelling

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Duchenne muscular dystrophy (DMD), caused by dystrophin deficiency, presents a multifaceted challenge that affects both skeletal muscle function and cardiomyocyte homeostasis, causing progressive degeneration and life‐threatening cardiac complications by adolescence.
Marta Przymuszała, Marta Białobrzeska, Józef Dulak, Urszula Florczyk‐Soluch   +3 more
wiley   +1 more source

OPTEM-oHCM: OPtimal Targeted Polymer-based EMbolization for Obstructive Hypertrophic CardioMyopathy. [PDF]

JACC Case Rep
Martins Filho E, Schumann Munhoz T, Munhoz Júnior S.   +2 more
europepmc   +1 more source

Asymptomatic Hypertrophic Cardiomyopathy: Diagnosis and Therapy [PDF]

, 2017
Fuentes, V L, Wilkie, L J
core   +1 more source

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [PDF]

Heart, 1964
J, COHEN, H, EFFAT, J F, GOODWIN, C M, OAKLEY, R E, STEINER   +4 more
openaire   +2 more sources

Novel Echocardiographic Index for Risk Stratification of Ventricular Arrhythmias and Mortality Based on Right Ventricular Function

Journal of Arrhythmia, Volume 42, Issue 1, February 2026.
Patients undergoing ICD implantation with both preprocedural echocardiography and cardiac magnetic resonance (CMR) were retrospectively analyzed to assess right ventricular (RV) function. Echocardiographic RV fractional area change (RVFAC) and the contraction pressure index (CPI), as well as CMR‐derived RV ejection fraction (RVEF), predicted ...
Toshinori Chiba, Takatsugu Kajiyama, Yusuke Kondo, Hiroyuki Takaoka, Noriko Suzuki‐Eguchi, Masahiro Nakano, Miyo Nakano, Satoko Ryuzaki, Yukiko Takanashi, Yuya Komai, Yusei Nishikawa, Yoshio Kobayashi   +11 more
wiley   +1 more source